Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis

<i>Coot</i> : model-building tools for molecular graphics

Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · see citing works

PROCHECK: a program to check the stereochemical quality of protein structures

Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581 · see citing works

<i>Phaser</i> crystallographic software

McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612 · see citing works

Refinement of Macromolecular Structures by the Maximum-Likelihood Method

Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,671 · see citing works

Calcium's Role in Mechanotransduction during Muscle Development

Damm, T. B., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,548 · see citing works

Overview of the <i>CCP</i> 4 suite and current developments

Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353 · see citing works

Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+

Bootman, M. D., Missiaen, L., Parys, J. B., SMEDT, H. D., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,120 · see citing works

In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903 · see citing works

PRODRG: a tool for high-throughput crystallography of protein–ligand complexes

Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,815 · see citing works

Multiple sclerosis

Compston, A., & Coles, A. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,459 · see citing works

Axonal transection in the lesions of multiple sclerosis

Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029 · see citing works

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids

Davis, I., Leaver‐Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J. S., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,915 · see citing works

Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death

Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005) · Nature · doi:10.1038/nature03434 · Cited by 2,280 · see citing works

Transcriptional regulation by calcium, calcineurin, and NFAT

Hogan, P. G., Chen, L., Nardone, J., & Rao, A. (2003) · Genes &amp; Development · doi:10.1101/gad.1102703 · Cited by 1,991 · see citing works

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977 · see citing works

Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death

Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., & Tsujimoto, Y. (2005) · Nature · doi:10.1038/nature03317 · Cited by 1,635 · see citing works

REFMAC 5 dictionary: organization of prior chemical knowledge and guidelines for its use

Vagin, A. A., Steiner, R. A., Lebedev, A. A., Potterton, L., McNicholas, S. J., Long, F., & Murshudov, G. N. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904023510 · Cited by 1,351 · see citing works

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,108 · see citing works

Dimers of mitochondrial ATP synthase form the permeability transition pore

Giorgio, V., von Stockum, S., Antoniel, M., Fabbro, A., Fogolari, F., Forte, M. A., Glick, G. D., Petronilli, V., Zoratti, M., Szabó, I., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217823110 · Cited by 924 · see citing works

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

Dutta, R., McDonough, J., Yin, X., Peterson, J. W., Chang, A., Torres, T., Gudz, T. I., Macklin, W. B., Lewis, D., Fox, R., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20736 · Cited by 881 · see citing works

Targeting Mitochondria

Hoye, A. T., Davoren, J. E., Wipf, P., Fink, M. P., & Kagan, V. E. (2008) · Accounts of Chemical Research · doi:10.1021/ar700135m · Cited by 636 · see citing works

An uncoupling channel within the c-subunit ring of the F 1 F O ATP synthase is the mitochondrial permeability transition pore

Alavian, K. N., Beutner, G., Lazrove, E., Sacchetti, S., Park, H., Licznerski, P., Li, H., Nabili, P., Hockensmith, K., Graham, M. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401591111 · Cited by 595 · see citing works

Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization

Nikolovska‐Coleska, Z., Wang, R., Fang, X., Pan, H., Tomita, Y. A., Li, P., Roller, P. P., Krajewski, K., Saito, N. G., Stuckey, J. A., et al. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.05.055 · Cited by 555 · see citing works

Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology

Ross, M. F., Kelso, G. F., Blaikie, F. H., James, A. M., Cochemé, H. M., Filipovska, A., Ros, T. D., Hurd, T. R., Smith, R. A. J., & Murphy, M. P. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0104-5 · Cited by 495 · see citing works

The mitochondrial permeability transition: A current perspective on its identity and role in ischaemia/reperfusion injury

Halestrap, A. P., & Richardson, A. P. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.08.018 · Cited by 466 · see citing works

HIV-1 evades innate immune recognition through specific cofactor recruitment

Rasaiyaah, J., Tan, C. P., Fletcher, A. J., Price, A. J., Blondeau, C., Hilditch, L., Jacques, D. A., Selwood, D. L., James, L. C., Noursadeghi, M., et al. (2013) · Nature · doi:10.1038/nature12769 · Cited by 456 · see citing works

Role of the c subunit of the F O ATP synthase in mitochondrial permeability transition

Bonora, M., Bononi, A., Marchi, E. D., Giorgi, C., Lebiedzińska, M., Marchi, S., Patergnani, S., Rimessi, A., Suski, J. M., Wojtala, A., et al. (2013) · Cell Cycle · doi:10.4161/cc.23599 · Cited by 454 · see citing works

Mitochondrial defects in acute multiple sclerosis lesions

Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406 · see citing works

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer’s disease: Implications to mitochondria-targeted antioxidant therapeutics

Reddy, P. H., Tripathi, R., Troung, Q., Tirumala, K., Reddy, T. P., Anekonda, V., Shirendeb, U. P., Calkins, M. J., Reddy, A. P., Mao, P., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.011 · Cited by 394 · see citing works

Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice.

Amor, S., Groome, N. P., Linington, C., Morris, M. M., Dornmair, K., Gardinier, M. V., Matthieu, J., & Baker, D. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4349 · Cited by 381 · see citing works

The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients: Mitoquinone and liver damage

Gane, E. J., Weilert, F., Orr, D. W., Keogh, G. F., Gibson, M., Lockhart, M. M., Frampton, C. M., Taylor, K. M., Smith, R. A. J., & Murphy, M. P. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02250.x · Cited by 379 · see citing works

Cyclophilin D Modulates Mitochondrial F0F1-ATP Synthase by Interacting with the Lateral Stalk of the Complex

Giorgio, V., Bisetto, E., Soriano, M. E., Dabbeni‐Sala, F., Basso, E., Petronilli, V., Forte, M. A., Bernardi, P., & Lippe, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020115 · Cited by 306 · see citing works

Pathology of multiple sclerosis and related inflammatory demyelinating diseases

Kutzelnigg, A., & Lassmann, H. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00002-9 · Cited by 302 · see citing works

Structural and Biochemical Characterization of the Human Cyclophilin Family of Peptidyl-Prolyl Isomerases

Davis, T. L., Walker, J. R., Campágna‐Slater, V., Finerty, P. J., Paramanathan, R., Bernstein, G., MacKenzie, F., Tempel, W., Ouyang, H., Lee, W. H., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000439 · Cited by 301 · see citing works

PharmGKB summary

Barbarino, J. M., Staatz, C. E., Venkataramanan, R., Klein, T. E., & Altman, R. B. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328364db84 · Cited by 260 · see citing works

The Mitochondrial Permeability Transition

Halestrap, A. P. (2002) · Springer eBooks · doi:10.1007/978-3-642-58268-4_12 · Cited by 260 · see citing works

Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration

Kapoor, R., Davies, M., Blaker, P. A., Hall, S. M., & Smith, K. J. (2002) · Annals of Neurology · doi:10.1002/ana.10443 · Cited by 252 · see citing works

Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model

Du, H., Guo, L., Zhang, W., Rydzewska, M., & Yan, S.-D. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.003 · Cited by 230 · see citing works

Mitochondrially targeted compounds and their impact on cellular bioenergetics

Reily, C., Mitchell, T., Chacko, B. K., Benavides, G. A., Murphy, M. P., & Darley-Usmar, V. M. (2013) · Redox Biology · doi:10.1016/j.redox.2012.11.009 · Cited by 227 · see citing works

Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis

Forte, M., Gold, B., Marracci, G., Chaudhary, P., Basso, E., Johnsen, D., Yu, X.-L., Fowlkes, J., Rahder, M., Stem, K., et al. (2007) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0702228104 · Cited by 222 · see citing works

Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double‐blinded, placebo‐controlled clinical trial

The Multiple Sclerosis Study Group, & Wolinsky (1990) · Annals of Neurology · doi:10.1002/ana.410270603 · Cited by 217 · see citing works

Axonal Degeneration Is Mediated by the Mitochondrial Permeability Transition Pore

Barrientos, S. A., Martínez, N. W., Yoo, S., Jara, J. S., Zamorano, S., Hetz, C. A., Twiss, J. L., Álvarez, J., & Court, F. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4065-10.2011 · Cited by 207 · see citing works

In Vivo Gene Transfer to the Mouse Eye Using an HIV-Based Lentiviral Vector; Efficient Long-Term Transduction of Corneal Endothelium and Retinal Pigment Epithelium

Bainbridge, J., Stephens, C., Parsley, K., Demaison, C., Halfyard, A., Thrasher, A., & Ali, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301574 · Cited by 197 · see citing works

The mitochondrial permeability transition pore in motor neurons: Involvement in the pathobiology of ALS mice

Martin, L. J., Gertz, B., Pan, Y. H., Price, A. C., Molkentin, J. D., & Chang, Q. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.02.015 · Cited by 181 · see citing works

The blood-brain barrier and oncology: new insights into function and modulation

Bart, J., Groen, H. J. M., Hendrikse, N. H., van der Graaf, W. T. A., Vaalburg, W., & de Vries, E. G. E. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0194 · Cited by 179 · see citing works

Phosphate Is Essential for Inhibition of the Mitochondrial Permeability Transition Pore by Cyclosporin A and by Cyclophilin D Ablation

Basso, E., Petronilli, V., Forte, M. A., & Bernardi, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800132200 · Cited by 167 · see citing works

Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake

Chung, N., & Wasan, K. M. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.003 · Cited by 158 · see citing works

The central role of mitochondria in axonal degeneration in multiple sclerosis

Campbell, G. R., Worrall, J. T., & Mahad, D. (2014) · Multiple Sclerosis · doi:10.1177/1352458514544537 · Cited by 137 · see citing works

Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity

Millard, M., Pathania, D., Shabaik, Y., Taheri, L., Deng, J., & Neamati, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013131 · Cited by 129 · see citing works

Imaging of Mitochondrial Polarization and Depolarization with Cationic Fluorophores

Lemasters, J. J., & Ramshesh, V. K. (2007) · Methods in cell biology · doi:10.1016/s0091-679x(06)80014-2 · Cited by 125 · see citing works

The mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice

Martin, L. J., Semenkow, S., Hanaford, A. R., & Wong, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.008 · Cited by 123 · see citing works

Cyclophilin D Deficiency Rescues Axonal Mitochondrial Transport in Alzheimer’s Neurons

Guo, L., Du, H., Yan, S., Wu, X., McKhann, G. M., Chen, J. X., & Yan, S. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054914 · Cited by 118 · see citing works

Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease

Quintanilla, R. A., Jin, Y. N., Rommy von Bernhardi, M., & Johnson, G. V. W. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-45 · Cited by 114 · see citing works

Cyclosporine versus azathioprine in the long‐term treatment of multiple sclerosis—results of the german multicenter study

Kappos, L., Pätzold, U., Dommasch, D., Poser, S., Haas, J., Krauseneck, P., Malin, J. P., Fierz, W., Graffenried, B. U., & Gugerli, U. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230110 · Cited by 109 · see citing works

Attenuation of acute mitochondrial dysfunction after traumatic brain injury in mice by NIM811, a non-immunosuppressive cyclosporin A analog

Mbye, L. H., Singh, I. N., Sullivan, P. G., Springer, J. E., & Hall, E. D. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.09.025 · Cited by 109 · see citing works

Profile of alisporivir and its potential in the treatment of hepatitis C

Gallay, P. A., & Lin, L. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s30946 · Cited by 106 · see citing works

Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons

Ohno, N., Chiang, H., Mahad, D., Kidd, G. J., Liu, L., Ransohoff, R. M., Sheng, Z., Komuro, H., & Trapp, B. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401155111 · Cited by 104 · see citing works

Critical appraisal of animal models of multiple sclerosis

Baker, D., Gerritsen, W. H., Rundle, J., & Amor, S. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511398885 · Cited by 99 · see citing works

Mitochondrial dysfunction and neurodegeneration in multiple sclerosis

Su, K., BOURDETTE, D. N., & Forte, M. A. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00169 · Cited by 93 · see citing works

Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options

Milić, S., Mikolašević, I., Zrnić, I. K., Stanić, M., Poropat, G., Štimac, D., Vlahović-Palčevski, V., & Orlić, L. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s64877 · Cited by 91 · see citing works

Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation

Jackson, S. J., Pryce, G., Diemel, L. T., Cuzner, M. L., & Baker, D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.02.045 · Cited by 81 · see citing works

Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis

Pryce, G., O'Neill, J. K., Croxford, J. L., Amor, S., Hankey, D. J. R., East, E., Giovannoni, G., & Baker, D. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.009 · Cited by 76 · see citing works

Post-Injury Administration of the Mitochondrial Permeability Transition Pore Inhibitor, NIM811, Is Neuroprotective and Improves Cognition after Traumatic Brain Injury in Rats

Readnower, R. D., Pandya, J. D., McEwen, M. L., Pauly, J. R., Springer, J. E., & Sullivan, P. G. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.1755 · Cited by 74 · see citing works

Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse

Al-Izki, S., Pryce, G., O'Neill, J. K., Butter, C., Giovannoni, G., Amor, S., & Baker, D. (2012) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2011.09.001 · Cited by 73 · see citing works

Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation

Malouitre, S. D. M., Dube, H., Selwood, D. L., & Crompton, M. (2009) · Biochemical Journal · doi:10.1042/bj20090332 · Cited by 71 · see citing works

Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure

Lim, S. Y., Hausenloy, D. J., Arjun, S., Price, A. N., Davidson, S. M., Lythgoe, M. F., & Yellon, D. M. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01235.x · Cited by 67 · see citing works

Isolation and Characterization of Cells Infiltrating the Spinal Cord during the Course of Chronic Relapsing Experimental Allergic Encephalomyelitis in the Biozzi AB/H Mouse

Allen, S. J., Baker, D., O'Neill, J. K., DAVISON, A. N., & Turk, J. L. (1993) · Cellular Immunology · doi:10.1006/cimm.1993.1031 · Cited by 66 · see citing works

Crystal structure of human cyclophilin D in complex with its inhibitor, cyclosporin A at 0.96‐Å resolution

Kajitani, K., Fujihashi, M., Kobayashi, Y., Shimizu, S., Tsujimoto, Y., & Miki, K. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21855 · Cited by 64 · see citing works

Truncation of TRIM5 in the Feliformia Explains the Absence of Retroviral Restriction in Cells of the Domestic Cat

McEwan, W. A., Schaller, T., Ylinen, L. M. J., Hosie, M. J., Towers, G. J., & Willett, B. J. (2009) · Journal of Virology · doi:10.1128/jvi.00670-09 · Cited by 58 · see citing works

Traumatic brain injury-induced axonal phenotypes react differently to treatment

Hånell, A., Greer, J. E., McGinn, M. J., & Povlishock, J. T. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1376-x · Cited by 55 · see citing works

Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica

Kageyama, T., Komori, M., Miyamoto, K., Ozaki, A., Suenaga, T., Takahashi, R., Kusunoki, S., Matsumoto, S., & Kondo, T. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6692-2 · Cited by 53 · see citing works

Conformational Adaptation of Asian Macaque TRIMCyp Directs Lineage Specific Antiviral Activity

Ylinen, L. M. J., Price, A. J., Rasaiyaah, J., Hué, S., Rose, N. J., Marzetta, F., James, L. C., & Towers, G. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001062 · Cited by 49 · see citing works

Modulation of F0F1‐ATP synthase activity by cyclophilin D regulates matrix adenine nucleotide levels

Chinopoulos, C., Konràd, C., Kiss, G., Metelkin, E., Törőcsik, B., Zhang, S. F., & Starkov, A. A. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08026.x · Cited by 47 · see citing works

The Mitochondrial Antioxidants MitoE 2 and MitoQ 10 Increase Mitochondrial Ca 2+ Load upon Cell Stimulation by Inhibiting Ca 2+ Efflux from the Organelle

Leo, S., Szabadkai, G., & Rizzuto, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.019 · Cited by 47 · see citing works

The P66Shc/mitochondrial permeability transition pore pathway determines neurodegeneration

Savino, C., Pelicci, P., & Giorgio, M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/719407 · Cited by 46 · see citing works

A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes

Dube, H., Selwood, D. L., Malouitre, S. D. M., Capano, M., Simone, M. I., & Crompton, M. (2011) · Biochemical Journal · doi:10.1042/bj20111301 · Cited by 45 · see citing works

Transplant international : official journal of the European Society for Organ Transplantation.

Transplantationsgesellschaft, D. (1988) · Cited by 44 · see citing works

Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis

Al‐Izki, S., Pryce, G., Hankey, D. J. R., Lidster, K., von Kutzleben, S., Browne, L., Clutterbuck, L. A., Posada, C., Chan, A. W. E., Amor, S., et al. (2013) · Brain · doi:10.1093/brain/awt324 · Cited by 43 · see citing works

Crystal engineering yields crystals of cyclophilin D diffracting to 1.7 Å resolution

Schlatter, D., Thoma, R., Küng, E., Stihle, M., Müller, F., Borroni, E., Cesura, A. M., & Hennig, M. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905003070 · Cited by 43 · see citing works

Quantification of Myelin and Axon Pathology During Relapsing Progressive Experimental Autoimmune Encephalomyelitis in the Biozzi ABH Mouse

Jackson, S. J., Lee, J., Nikodemova, M., Fabry, Z., & Duncan, I. D. (2009) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181a41d23 · Cited by 38 · see citing works

Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2?,3? cyclic nucleotide 3? phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAE

Birnbaum, G., Kotilinek, L., Schlievert, P. M., Clark, H. B., Trotter, J. L., Horváth, E., Gao, E. N., Cox, M. E., & Braun, P. E. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960515)44:4 · Cited by 38 · see citing works

Therapy of chronic relapsing experimental allergic encephalomyelitis and the role of the blood-brain barrier: elucidation by the action of Brequinar sodium

O'Neill, J. K., Baker, D., DAVISON, A. N., Maggon, K. K., JAFFEE, B. D., & Turk, J. L. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90090-8 · Cited by 34 · see citing works

Cyclophilin D is expressed predominantly in mitochondria of γ‐aminobutyric acidergic interneurons

Hazelton, J. L., Petrasheuskaya, M., Fiskum, G. M., & Kristián, T. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21921 · Cited by 34 · see citing works

Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis

Hampton, D. W., Serio, A., Pryce, G., Al-Izki, S., Franklin, R. J., Giovannoni, G., Baker, D., & Chandran, S. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-84 · Cited by 34 · see citing works

Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon

Marta, M., & Giovannoni, G. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712801661301 · Cited by 33 · see citing works

The targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imaging

Kato, M., Akao, M., Matsumoto-Ida, M., Makiyama, T., Iguchi, M., Takeda, T., Shimizu, S., & Kita, T. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp094 · Cited by 31 · see citing works

Relationship between lipophilicity of BCS class III and IV drugs and the functional activity of peroral absorption enhancers

Sharma, P. K., Varma, M. V. S., Chawla, H. P. S., & Panchagnula, R. (2005) · Il Farmaco · doi:10.1016/j.farmac.2005.08.006 · Cited by 29 · see citing works

Control of spasticity in a multiple sclerosis model using central nervous system‐excluded CB 1 cannabinoid receptor agonists

Pryce, G., Visintin, C., Ramagopalan, S. V., Al‐Izki, S., Faveri, L. E. D., Nuamah, R. A., Mein, C. A., Montpetit, A., Hardcastle, A. J., Kooij, G., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-239442 · Cited by 29 · see citing works

Genetic inactivation of the p66 isoform of ShcA is neuroprotective in a murine model of multiple sclerosis

Su, K., Savino, C., Marracci, G., Chaudhary, P., Yu, X., Morris, B., Galipeau, D., Giorgio, M., Forte, M. A., & BOURDETTE, D. N. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07972.x · Cited by 28 · see citing works

Synthesis of Cyclosporin A-Derived Affinity Reagents by Olefin Metathesis

Smulik, J. A., Diver, S. T., Pan, F., & Liu, J. O. (2002) · Organic Letters · doi:10.1021/ol0258987 · Cited by 26 · see citing works

P-glycoprotein (Mdr1a/1b) and breast cancer resistance protein (Bcrp) decrease the uptake of hydrophobic alkyl triphenylphosphonium cations by the brain

Porteous, C. M., Menon, D. K., Aigbirhio, F. I., Smith, R. A. J., & Murphy, M. P. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.005 · Cited by 25 · see citing works

A fluorescence polarization-based assay for peptidyl prolyl cis/trans isomerase cyclophilin A

Liu, Y., Jiang, J., Richardson, P. L., Reddy, R. D., Johnson, D. D., & Kati, W. M. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.04.040 · Cited by 23 · see citing works

Plasmodium berghei: In vitro and in vivo activity of dequalinium

Rodrigues, J. R., & de Domı́nguez, N. G. (2006) · Experimental Parasitology · doi:10.1016/j.exppara.2006.05.002 · Cited by 17 · see citing works

A Case of Severe Cerebral Trauma in a Patient Under Chronic Treatment with Cyclosporine A

Gogarten, W., Aken, H. V., Moskopp, D., Roos, N., Schleef, J., Marcus, M. A. E., & Meyer, J. (1998) · Journal of Neurosurgical Anesthesiology · doi:10.1097/00008506-199804000-00006 · Cited by 17 · see citing works

Yin and Yang in Medicinal Chemistry: What Does Drug-Likeness Mean?

Macarrón, R., & Luengo, J. I. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.19 · Cited by 16 · see citing works

Blocking the mitochondrial permeability transition pore with cyclosporine-A can restore cardioprotection of ischemic postconditioning in hypercholesterolemic rat heart.

Wu, N., Li, W., Wq, S., Lv, Y., & Jia, D.-L. (2015) · PubMed · Cited by 14 · see citing works

Facile Synthesis of a Fluorescent Cyclosporin A Analogue To Study Cyclophilin 40 and Cyclophilin 18 Ligands

Gaali, S., Kozany, C., Hoogeland, B., Klein, M., & Hausch, F. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1001272 · Cited by 13 · see citing works

No evidence for a local renin-angiotensin system in liver mitochondria

Astin, R., Bentham, R. B., Djafarzadeh, S., Horscroft, J. A., Kuc, R. E., Leung, P. S., Skipworth, J. R. A., Vicencio, J. M., Davenport, A. P., Murray, A. J., et al. (2013) · Scientific Reports · doi:10.1038/srep02467 · Cited by 12 · see citing works

Case Study 5. Deconvoluting Hyperbilirubinemia: Differentiating Between Hepatotoxicity and Reversible Inhibition of UGT1A1, MRP2, or OATP1B1 in Drug Development

Templeton, I. E., Eichenbaum, G. M., Sane, R. S., & Zhou, J. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-758-7_22 · Cited by 10 · see citing works

High-resolution crystal structures of two crystal forms of human cyclophilin D in complex with PEG 400 molecules

Valasani, K. R., Carlson, E. A., Battaile, K. P., Bisson, A., Wang, C., Lovell, S., & Yan, S. S. (2014) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x14009480 · Cited by 7 · see citing works

Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine

Hecking, M., Kainz, A., Schillinger, M., Posch, C., Bı̂rsan, T., Rasoul‐Rockenschaub, S., Böhmig, G. A., Schmaldienst, S., Watschinger, B., Hörl, W. H., et al. (2007) · Transplant International · doi:10.1111/j.1432-2277.2007.00563.x · Cited by 3 · see citing works

Sodium channel blockade with phenytoin has a neuroprotective effect on the ganglion cell complex after acute optic neuritis

Raftopoulos, R., Rangarajan, A., Chen, C.-L., Hickman, S. J., Toosy, A., Wheeler‐Kingshott, C. A. M. G., Altmann, D. R., Malik, S., Paling, D., Yiannakas, M. C., et al. (2015) · UCL Discovery (University College London) · Cited by 2 · see citing works

Untitled work

Kordower (1999) · doi:10.1002/1531-8249(199909)46:3

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.

Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death &amp; Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works

The machineries, regulation and cellular functions of mitochondrial calcium

Giorgi, C., Marchi, S., & Pinton, P. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0052-8 · Cited by 941 · see citing works

Molecular mechanisms and consequences of mitochondrial permeability transition

Bonora, M., Giorgi, C., & Pinton, P. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00433-y · Cited by 549 · see citing works

Mitochondrial permeability transition pore is a potential drug target for neurodegeneration

Rao, V. K., Carlson, E. A., & Yan, S. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.003 · Cited by 325 · see citing works

The path from mitochondrial <scp>ROS</scp> to aging runs through the mitochondrial permeability transition pore

Rottenberg, H., & Hoek, J. B. (2017) · Aging Cell · doi:10.1111/acel.12650 · Cited by 275 · see citing works

Cell death mechanisms in eukaryotes

Nirmala, J. G., & Lopus, M. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09496-2 · Cited by 266 · see citing works

PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease

Corona, J. C., & Duchen, M. R. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.023 · Cited by 259 · see citing works

The neuropathobiology of multiple sclerosis

Woo, M. S., Engler, J. B., & Friese, M. A. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00823-z · Cited by 194 · see citing works

Mitochondrial Permeability Transition: A Molecular Lesion with Multiple Drug Targets

Briston, T., Selwood, D. L., Szabadkai, G., & Duchen, M. R. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.11.004 · Cited by 185 · see citing works

Mitochondrial calcium transport and the redox nature of the calcium-induced membrane permeability transition

Vercesi, A. E., Castilho, R. F., Kowaltowski, A. J., Oliveira, H. C. F., de Souza-Pinto, N. C., Figueira, T. R., & Busanello, E. N. B. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.034 · Cited by 141 · see citing works

Physiopathology of the Permeability Transition Pore: Molecular Mechanisms in Human Pathology

Bonora, M., Patergnani, S., Ramaccini, D., Morciano, G., Pedriali, G., Kahsay, A., Bouhamida, E., Giorgi, C., Wieckowski, M., & Pinton, P. (2020) · Biomolecules · doi:10.3390/biom10070998 · Cited by 135 · see citing works

Mechanisms of Regulated Cell Death: Current Perspectives

Santagostino, S. F., Assenmacher, C., Tarrant, J. C., Adedeji, A. O., & Radaelli, E. (2021) · Veterinary Pathology · doi:10.1177/03009858211005537 · Cited by 133 · see citing works

Modulation of innate immunity by cyclosporine A

Liddicoat, A. M., & Lavelle, E. C. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.022 · Cited by 127 · see citing works

Neuron-Oligodendrocyte Interactions in the Structure and Integrity of Axons

Duncan, G. J., Simkins, T., & Emery, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.653101 · Cited by 121 · see citing works

Mitochondrial permeability transition pore: a potential drug target for neurodegeneration

Kalani, K., Yan, S. F., & Yan, S. S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.08.001 · Cited by 117 · see citing works

Cyclophilin D, Somehow a Master Regulator of Mitochondrial Function

Porter, G. A., & Beutner, G. (2018) · Biomolecules · doi:10.3390/biom8040176 · Cited by 114 · see citing works

Cyclophilin D: An Integrator of Mitochondrial Function

Amanakis, G., & Murphy, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00595 · Cited by 103 · see citing works

Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression

He, R., Liu, Y., Fu, W., He, X., Liu, S., Xiao, D., & Tao, Y. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02172-y · Cited by 99 · see citing works

Nitric Oxide and Mitochondrial Function in Neurological Diseases

Ghasemi, M., Mayasi, Y. M., Hannoun, A., Eslami, S. M., & Carandang, R. A. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.017 · Cited by 93 · see citing works

Cannabidiol activates PINK1-Parkin-dependent mitophagy and mitochondrial-derived vesicles

Ramirez, A., Old, W. M., Selwood, D. L., & Liu, X. (2021) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2021.151185 · Cited by 76 · see citing works

Smoking induces DNA methylation changes in Multiple Sclerosis patients with exposure-response relationship

Marabita, F., Almgren, M., Sjöholm, L. K., Kular, L., Liu, Y., James, T., Kiss, N. B., Feinberg, A. P., Olsson, T. P., Kockum, I. S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14788-w · Cited by 73 · see citing works

Mitochondrial Permeability Transition, Cell Death and Neurodegeneration

Baev, A. Y., Vinokurov, A. Y., Potapova, E., Dunaev, A., Angelova, P. R., & Abramov, A. Y. (2024) · Cells · doi:10.3390/cells13070648 · Cited by 65 · see citing works

F1F0 ATP Synthase–Cyclophilin D Interaction Contributes to Diabetes-Induced Synaptic Dysfunction and Cognitive Decline

Yan, S., Wu, L., Wu, L., Zhong, C., Zhong, C., Yu, Q., Wang, Y., Lue, L., Douglas, J. T., Douglas, J. T., et al. (2016) · Diabetes · doi:10.2337/db16-0556 · Cited by 54 · see citing works

Wnt Signaling Prevents the Aβ Oligomer-Induced Mitochondrial Permeability Transition Pore Opening Preserving Mitochondrial Structure in Hippocampal Neurons

Arrázola, M. S., Ramos‐Fernández, E., Cisternas, P., Ordenes, D., & Inestrosa, N. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168840 · Cited by 49 · see citing works

Targeting the mitochondrial permeability transition pore for drug discovery: Challenges and opportunities

Boyenle, I. D., Oyedele, A.-Q. K., Ogunlana, A. T., Adeyemo, A. F., Oyelere, S. F., Akinola, O. B., Adelusi, T. I., Ehigie, L. O., & Ehigie, A. F. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.01.006 · Cited by 48 · see citing works

Estrogen receptor beta modulates permeability transition in brain mitochondria

Burstein, S. R., Kim, H. J., Fels, J. A., Qian, L., Zhang, S., Zhou, P., Starkov, A. A., Iadecola, C., & Manfredi, G. (2018) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2018.03.006 · Cited by 48 · see citing works

Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities

Gurung, D., Danielson, J. A., Tasnim, A., Zhang, J.-T., Zou, Y., & Liu, J.-Y. (2023) · Biology · doi:10.3390/biology12071008 · Cited by 36 · see citing works

Sex Differences in Ischemia/Reperfusion Injury: The Role of Mitochondrial Permeability Transition

Fels, J. A., & Manfredi, G. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02769-6 · Cited by 45 · see citing works

Lipophilic Cations as Mitochondria-Targeting Moieties: Recent Progress and Design Principles for Medicinal Chemistry

Džajić, I., Tomašič, T., Pardo, L. A., Mašič, L. P., & Cotman, A. E. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02076 · Cited by 40 · see citing works

Hepatitis C virus exploits cyclophilin A to evade PKR

Colpitts, C. C., Ridewood, S., Schneiderman, B., Warne, J. M., Tabata, K., Ng, C. F., Bartenschlager, R., Selwood, D. L., & Towers, G. J. (2020) · eLife · doi:10.7554/elife.52237 · Cited by 40 · see citing works

Small‐molecule inhibitors of cyclophilin D as potential therapeutics in mitochondria‐related diseases

Haleckova, A., Benek, O., Zemanová, L., Doležal, R., & Musílek, K. (2022) · Medicinal Research Reviews · doi:10.1002/med.21892 · Cited by 38 · see citing works

Discovery and molecular basis of subtype-selective cyclophilin inhibitors

Peterson, A. A., Rangwala, A. M., Thakur, M. K., Ward, P. S., Hung, C., Outhwaite, I. R., Chan, A. I., Usanov, D. L., Mootha, V. K., Seeliger, M. A., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01116-1 · Cited by 37 · see citing works

Fighting cancer by triggering non-canonical mitochondrial permeability transition-driven necrosis through reactive oxygen species induction

Xiao, Q., Zhong, B., Hou, Y., Wang, M., Guo, B., Lin, L., Zhou, Y., & Chen, X. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.03.020 · Cited by 34 · see citing works

A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry

Zucchi, E., Lu, C., Cho, Y., Chang, R., Adiutori, R., Zubiri, I., Ceroni, M., Cereda, C., Pansarasa, O., Greensmith, L., et al. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14542 · Cited by 32 · see citing works

Protective effects of leptin against cerebral ischemia/reperfusion injury (Review)

Zhang, W., Jin, Y., Li, X., Yang, Z., Wang, D., & Cui, J. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7377 · Cited by 33 · see citing works

Non‐Immunosuppressive Cyclophilin Inhibitors

Schiene‐Fischer, C., Fischer, G. S., & Braun, M. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202201597 · Cited by 33 · see citing works

Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV

Newton, L. S., Gathmann, C., Ridewood, S., Smith, R. J., Wijaya, A. J., Hornsby, T. W., Morling, K. L., Davison, D., Chiozzi, R. Z., Reuschl, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56317-8 · Cited by 31 · see citing works

Identification of ER-000444793, a Cyclophilin D-independent inhibitor of mitochondrial permeability transition, using a high-throughput screen in cryopreserved mitochondria

Briston, T., Lewis, S., Koglin, M., Mistry, K., Shen, Y., Hartopp, N., Katsumata, R., Fukumoto, H., Duchen, M. R., Szabadkai, G., et al. (2016) · Scientific Reports · doi:10.1038/srep37798 · Cited by 30 · see citing works

Discovery of 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: A new modulator for amyloid beta-induced mitochondrial dysfunction

Elkamhawy, A., Park, J.-E., Hassan, A. H. E., Ra, H., Pae, A. N., Lee, J., Park, B.-G., Moon, B., Park, H., & Roh, E. J. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.12.057 · Cited by 31 · see citing works

Shutting down the pore: The search for small molecule inhibitors of the mitochondrial permeability transition

Šileikytė, J., & Forte, M. A. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.02.016 · Cited by 30 · see citing works

Pathogenic synergy: dysfunctional mitochondria and neuroinflammation in neurodegenerative diseases associated with aging

Mani, S., Wasnik, S., Shandilya, C., Srivastava, V., Khan, S., & Singh, K. K. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1615764 · Cited by 28 · see citing works

Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds

Biasutto, L., Mattarei, A., Spina, M. L., Azzolini, M., Parrasia, S., Szabó, I., & Zoratti, M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.060 · Cited by 26 · see citing works

Picroside II Exerts a Neuroprotective Effect by Inhibiting mPTP Permeability and EndoG Release after Cerebral Ischemia/Reperfusion Injury in Rats

Li, S., Wang, T., Zhai, L., Ge, K., Zhao, J., Cong, W., & Guo, Y. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-1012-z · Cited by 26 · see citing works

Transcriptional regulation of cyclophilin D by BMP/Smad signaling and its role in osteogenic differentiation

Sautchuk, R., Kalicharan, B. H., Escalera-Rivera, K., Jonason, J. H., Porter, G. A., Jr., Awad, H. A., & Eliseev, R. A. (2022) · eLife · doi:10.7554/elife.75023 · Cited by 26 · see citing works

Neuroprotection Effect of Astragaloside IV from 2-DG-Induced Endoplasmic Reticulum Stress

Fu, Y., Cai, J., Xi, M., He, Y., Yang, Z., Zheng, Y., Zhang, Y., Xi, J., & He, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9782062 · Cited by 24 · see citing works

Targeting putative components of the mitochondrial permeability transition pore for novel therapeutics

Winquist, R. J., & Gribkoff, V. K. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113995 · Cited by 25 · see citing works

The involvement of the mitochondrial membrane in drug delivery

Huang, Y., Ji, W., Zhang, J., Huang, Z. H., Ding, A., Bai, H., Peng, B., Huang, K., Du, W., Zhao, T., et al. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.01.027 · Cited by 24 · see citing works

Emerging small-molecule treatments for multiple sclerosis: focus on B cells

Gregson, A. M., Thompson, K. K., Tsirka, S. E., & Selwood, D. L. (2019) · F1000Research · doi:10.12688/f1000research.16495.1 · Cited by 21 · see citing works

An Inhibitor of the Interaction of Survivin with Smac in Mitochondria Promotes Apoptosis

Park, S., Shin, I.-S., Park, S., Kim, N. D., & Shin, I. (2019) · Chemistry - An Asian Journal · doi:10.1002/asia.201900587 · Cited by 20 · see citing works

Role of the Mitochondrial Permeability Transition in Bone Metabolism and Aging

Sautchuk, R., Chen, Y., McArthur, M. J., Massie, C. M., Brookes, P. S., Porter, G. A., Jr., Awad, H. A., & Eliseev, R. A. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4787 · Cited by 19 · see citing works

Mitochondrial Cl–-Selective Fluorescent Probe for Biological Applications

Park, S.-H., Shin, I., Kim, Y.-H., & Shin, I. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02658 · Cited by 19 · see citing works

Biofilm-dispersal patterns in ESKAPE pathogens

Sahu, A., Jain, S. V., Junghare, M., Mishra, A., & Ruhal, R. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04394-0 · Cited by 16 · see citing works

WDR26/MIP2 interacts with VDAC1 and regulates VDAC1 expression levels in H9c2 cells

Jiang, L., Wang, H., Chen, G., Feng, Y., Zou, J., Liu, M., Liu, K., Wang, N., Zhang, H., Wang, K., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.015 · Cited by 16 · see citing works

Identification of small-molecule urea derivatives as PTPC modulators targeting the c subunit of F1/Fo-ATP synthase

Fantinati, A., Morciano, G., Turrin, G., Pedriali, G., Pacifico, S., Preti, D., Albanese, V., Illuminati, D., Cristofori, V., Giorgi, C., et al. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128822 · Cited by 15 · see citing works

Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson’s Disease

Wang, S., Zhang, S., Xu, C., Barron, A., Galiano, F. J., Patel, D. S., Lee, Y. J., Caldwell, G. A., Caldwell, K. A., & Witt, S. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164465 · Cited by 14 · see citing works

Melatonin-Induced Postconditioning Suppresses NMDA Receptor through Opening of the Mitochondrial Permeability Transition Pore via Melatonin Receptor in Mouse Neurons

Furuta, T., Nakagawa, I., Yokoyama, S., Morisaki, Y., Saito, Y., & Nakase, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073822 · Cited by 13 · see citing works

Experimental autoimmune encephalomyelitis from a tissue energy perspective

Desai, R. A., & Smith, K. J. (2017) · F1000Research · doi:10.12688/f1000research.11839.1 · Cited by 13 · see citing works

Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives

Olesen, M. A., Villavicencio-Tejo, F., Cuevas-Espinoza, V., & Quintanilla, R. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102594 · Cited by 12 · see citing works

Cyclophilin D-induced mitochondrial impairment confers axonal injury after intracerebral hemorrhage in mice

Wang, Y., Zhang, K.-Y., Chen, X., Yang, C.-Y., Wang, J., Lei, X., Quan, Y., Chen, W., Zhao, H., Yang, L., et al. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.353495 · Cited by 12 · see citing works

Inorganic nitrite increases the susceptibility of tilapia (Oreochromis niloticus) leucocytes to Streptococcus agalactiae

Zhao, Z., Sun, C., Chen, L., Qin, J., Yuan, X., & Li, W. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.12.039 · Cited by 12 · see citing works

Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond

Perdaens, O., & Pesch, V. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312637 · Cited by 11 · see citing works

Cyclophilin inhibitor NIM811 ameliorates experimental allergic encephalomyelitis

Huang, Z. L., Pandya, D., Banta, D. K., Ansari, M. S., & Oh, U. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.07.016 · Cited by 10 · see citing works

Dissecting prostate Cancer: Single-Cell insight into Macrophage Diversity, molecular Prognosticators, and the role of Peptidylprolyl Isomerase F

Guan, B., Huang, C., Meng, L., Zhang, S., Liu, Q., Wang, X., Li, X., & Hao, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112599 · Cited by 9 · see citing works

Cladribine tablets in the new multiple sclerosis era

Buttari, F., Dolcetti, E., Rizzo, F. R., Rizzi, C., Lauritano, G., Borrelli, A., Azzolini, F., Fantozzi, R., Assogna, F., Conte, A., et al. (2025) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864251342855 · Cited by 8 · see citing works

One-bead-one-compound screening approach to the identification of cyclic peptoid inhibitors of cyclophilin D as neuroprotective agents from mitochondrial dysfunction

Hyun, S., Park, N., Nam, S. H., Cheon, D. H., Lee, Y., Lim, H., & Yu, J. (2021) · Chemical Communications · doi:10.1039/d0cc08268f · Cited by 8 · see citing works

Remyelinating Drugs at a Crossroad: How to Improve Clinical Efficacy and Drug Screenings

Jaf, A. I. A. A., Peria, S., Fabiano, T., & Ragnini‐Wilson, A. (2024) · Cells · doi:10.3390/cells13161326 · Cited by 7 · see citing works

Evaluating the potential of non‐immunosuppressive cyclosporin analogs for targeting Toxoplasma gondii cyclophilin: Insights from structural studies

Favretto, F., Jiménez‐Faraco, E., Catucci, G., Matteo, A. D., Travaglini‐Allocatelli, C., Sadeghi, S. J., Dominici, P., Hermoso, J. A., & Astegno, A. (2024) · Protein Science · doi:10.1002/pro.5157 · Cited by 7 · see citing works

Molecular signature associated with cladribine treatment in patients with multiple sclerosis

Fissolo, N., Calvo‐Barreiro, L., Eixarch, H., Boschert, U., Villar, L. M., Costa‐Frossard, L., Ferrer, M., Sánchez‐Pla, Á., Borràs, E., Sabidó, E., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1233546 · Cited by 7 · see citing works

Mitochondrial quality control in health and disease: mechanisms and therapeutic targets

Creus, A., Mohapatra, S., Ortega, L., & Sebastián, D. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02813-2 · Cited by 7 · see citing works

Delocalized quinolinium-macrocyclic peptides, an atypical chemotype for CNS penetration

Pingitore, V., Pancholi, J., Hornsby, T. W., Warne, J. M., Pryce, G., McCormick, L. J., Hill, J. M., Bhosale, G., Peng, J., Newton, L. S., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado3501 · Cited by 6 · see citing works

Mitochondrial Dysfunction Causes Cell Death in Patients Affected by Fragile-X-Associated Disorders

Grandi, M., Galber, C., Gatto, C., Nobile, V., Pucci, C., Nielsen, I. S., Boldrin, F., Neri, G., Chiurazzi, P., Solaini, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063421 · Cited by 6 · see citing works

In silico repurposing of CNS drugs for multiple sclerosis

Sardari, E., Ebadi, A., & Razzaghi‐Asl, N. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104622 · Cited by 5 · see citing works

Neuroprotection against beta-amyloid toxicity by the novel estrogen receptor modulator STX requires convergent signaling pathways

Lee, H., Bostick, Z., Doherty, J., Swanson, T. L., Kelly, M. J., Quinn, J. F., Gray, N. E., & Copenhaver, P. F. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1670646 · Cited by 4 · see citing works

Mitochondrial permeability transition pore (mPTP) as a target for drug delivery systems: challenges and opportunities

Singh, D. (2025) · Health Nanotechnology · doi:10.1186/s44301-025-00019-z · Cited by 4 · see citing works

Role of Mitochondrial Heat-shock Proteins and Immunophilins in Neuro Degenerative Diseases

Daneri-Becerra, C., Ciucci, S. M., Mazaira, G. I., & Galigniana, M. D. (2021) · Current Drug Targets · doi:10.2174/1389450121999201230204320 · Cited by 4 · see citing works

Mitochondria‐Targeting Moieties Based on N‐Tethered Pyridinium Cations

Džajić, I., Trunkelj, N., Repas, J., Kandušer, M., Smrdel, L., Pajk, S., Žiberna, L., Mlinarič‐Raščan, I., Markelc, B., Božič, T., et al. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.7158257 · Cited by 2 · see citing works

Neuroprotection in an Experimental Model of Multiple Sclerosis via Opening of Big Conductance, Calcium-Activated Potassium Channels

Pryce, G., Sisay, S., Giovannoni, G., Selwood, D. L., & Baker, D. (2023) · Pharmaceuticals · doi:10.3390/ph16070972 · Cited by 1 · see citing works

Human Cyclophilins—An Emerging Class of Drug Targets

Jurkova, K., Navrátilová, H., Musílek, K., & Benek, O. (2025) · Medicinal Research Reviews · doi:10.1002/med.70021 · Cited by 1 · see citing works

Pharmacological Regulation of Mitochondrial Pore as a Therapeutic Strategy in Neuroprotection (Review)

Федотчева, Т. А., Zemlyanaya, A. A., & Shimanovsky, N. L. (2025) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-025-03446-5 · Cited by 1 · see citing works

APOE4 exacerbates glucocorticoid stress hormone-induced tau pathology via mitochondrial dysfunction

Yu, Q., Du, F., Puerta-Alvarado, V., Goodman, J. H., & Waites, C. L. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08543-1 · Cited by 2 · see citing works

Organ Preservation, Ischemia Reperfusion Injury, and Nanotherapeutics in Transplantation

Patel, K., Atkinson, C., Broome, A., & Nadig, S. N. (2017) · Springer eBooks · doi:10.1007/978-3-319-62142-5_7 · Cited by 1 · see citing works

Neuroprotection and Recovery in Multiple Sclerosis

Muresanu, D. F., Balea, M., Roșu, O. V., Buzoianu, A. D., & Slăvoacă, D. (2016) · InTech eBooks · doi:10.5772/63829 · Cited by 1 · see citing works

Mitochondria are an Important Target in the Search for new Drugs for the Treatment of Alzheimer′s Disease and Senile Dementia

Shevtsova, E. F., Vinogradova, D. V., Евгеньевна, Н. М., Shevtsov, P. N., Lednev, B. V., & Бачурин, С. О. (2018) · Biomedical Chemistry Research and Methods · doi:10.18097/bmcrm00058 · Cited by 1 · see citing works

NLRX1 is an essential, druggable regulator of mitochondrial permeability transitionPreprint

Heap, R. E., Frederick, D. W., Pickering, R. J., Ghidelli‐Disse, S., Searle, K. L., Barber, J. C., Galwey, N. W., Wilhelm, L. P., Triantafilou, K., Triantafilou, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.24.746860 · Cited by 1 · see citing works

INAD and Duchenne muscular dystrophy, two ends of the iPLA2β spectrum

Offringa, A. K. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109589

Mitochondrial Permeability Regulates Cardiac Graft Ischemia-Reperfusion Injury and Allograft Rejection

Qamar, A. (2020) · Scholarship@Western (Western University)

Antimycobacterial Attributes of Mitochondria: An Insight into Host Defense Mechanisms

Dubey, R. K., & Narain, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-56905-1_9

Peptidyl-prolyl cis/trans isomerases in GtoPdb v.2021.2

Annett, S., & Robson, T. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f845/2021.2

Nicht‐immunsuppressive Cyclophilin‐Inhibitoren

Schiene‐Fischer, C., Fischer, G. S., & Braun, M. (2022) · Angewandte Chemie · doi:10.1002/ange.202201597

Mitochondria-targeted drug delivery systems for the effective treatment of neurodegenerative disorders

Khare, V., Gupta, S., Bisht, P., & Garabadu, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00013-7

Identification of Small-Molecule Urea Derivatives as Ptpc ModulatorsPreprint

Fantinati, A., Morciano, G., Turrin, G., Pedriali, G., Pacifico, S., Preti, D., Albanese, V., Illuminati, D., Cristofori, V., Giorgi, C., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4065213

Peptidyl-prolyl cis/trans isomerases in GtoPdb v.2023.1

Annett, S., & Robson, T. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f845/2023.1

Mitochondria Are a Potential Therapeutic Target for Alzheimer’s Disease

Basavalingiah, A. J., Yan, S. F., & Yan, S. S. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190932183.013.23

In silico and In vivo Studies of Calotropis procera leaf and root extracts on Mitochondrial-Related parameters in Wistar Rats

Adisa, A. D., Olabinri, P. F., Oyedeji, T. A., Ojeniyi, F. D., Agboola, J. B., Zubair, M. F., Ojo, G. J., Ehigie, L. O., & Ehigie, A. F. (2023) · doi:10.54117/ijmds.v2i1.18

Cell death in acetaminophen (APAP) toxicity

Shojaie, L., Alavifard, H., & Dara, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15877-3.00011-9

A modified cyclosporine enhances lentivector transduction ex vivo and in vivo by degrading IFITM3

Annett, D., Critchley, B. J., Morling, K. L., Graham, B., Pingitore, V., Whittaker, T. E., Kurdi, N., Warne, J. M., Moula, S. E., León‐Rico, D., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.07.056

Étude de l'effet de nouveaux ligands de la cyclophiline D sur le pore de transition de perméabilité mitochondrial et de leur effet protecteur

Panel, M. (2018) · theses.fr (ABES) · doi:10.70675/d2bc84b3z0f05z4b8eza15fz5ee06082fa4f

Mitochondria‐Targeting Moieties Based on N‐Tethered Pyridinium Cations

Džajić, I., Trunkelj, N., Repas, J., Kandušer, M., Smrdel, L., Pajk, S., Žiberna, L., Mlinarič‐Raščan, I., Markelc, B., Božič, T., et al. (2026) · Angewandte Chemie · doi:10.1002/ange.7158257

Measuring Calcium Efflux in Isolated Primary Mitochondria

Jones, T. M., Hurst, S. J., & Bround, M. J. (2026) · Current Protocols · doi:10.1002/cpz1.70393

BindingDB Entry 50006646: Discovery of 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: A new modulator for amyloid beta-induced mitochondrial dysfunction.

BindingDB (2020) · UC San Diego · doi:10.7270/q2q52sm6

Cyclophilin D-mediated Mitochondrial Permeability Transition Regulates Mitochondrial Function

Zhou, S., Yu, Q., Zhang, L., & Jiang, Z. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230313111314 · Cited by 27 · see citing works

Small‐molecule inhibitors of cyclophilin D as potential therapeutics in mitochondria‐related diseases

Haleckova, A., Benek, O., Zemanová, L., Doležal, R., & Musílek, K. (2022) · Medicinal Research Reviews · doi:10.1002/med.21892 · Cited by 38 · see citing works

Cyclophilin D: An Integrator of Mitochondrial Function

Amanakis, G., & Murphy, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00595 · Cited by 103 · see citing works

Mitochondrial permeability transition pore (mPTP); cyclophilin D (CYPD)

(2011) · Science-Business eXchange · doi:10.1038/scibx.2011.135

Cyclophilin D-Sensitive Mitochondrial Permeability Transition in Adult Human Brain and Liver Mitochondria

Hansson, M. J., Morota, S., Chen, L., Matsuyama, N., Suzuki, Y., Nakajima, S., Tanoue, T., Omi, A., Shibasaki, F., Shimazu, M., et al. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1613 · Cited by 40 · see citing works